PyInvesting

Market research

300138.SHE ChenGuang Biotech Group Co., Ltd

SHE CNY Consumer Defensive

Latest close

12.69 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
6B
P/E ratio
18.46
Analyst target
13.0767
Dividend yield
2.4%
Beta
0.42

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

ChenGuang Biotech Group Co., Ltd is currently in a long term downtrend where the price is trading 1.1% below its 200 day moving average.

From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.9.

ChenGuang Biotech Group Co., Ltd's total revenue rose by 25.6% to $1B since the same quarter in the previous year.

Its net income has increased by 35.2% to $62M since the same quarter in the previous year.

Finally, its free cash flow fell by 22.2% to $-991M since the same quarter in the previous year.

Based on the above factors, ChenGuang Biotech Group Co., Ltd gets an overall score of 3/5.